4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0000919574-21-003782
Director bought 180,000 shares at an average $2.18 ($392,460)
From the SEC's structured data for this filing
Trades in this filing
ARMISTICE CAPITAL, LLC · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-14 | Purchase : show line 1 in the form | +128,000 | $2.15 | $275,200 | 39,048,000 | D |
| 2021-05-14 | Purchase : show line 2 in the form | +0 | 39,048,000 | I | ||
| 2021-05-17 | Purchase : show line 3 in the form | +30,000 | $2.20 | $66,000 | 39,078,000 | D |
| 2021-05-17 | Purchase : show line 4 in the form | +0 | 39,078,000 | I | ||
| 2021-05-18 | Purchase : show line 5 in the form | +22,000 | $2.33 | $51,260 | 39,100,000 | D |
| 2021-05-18 | Purchase : show line 6 in the form | +0 | 39,100,000 | I | ||
| Open-market purchases · 180,000 sh · avg $2.18 · $392,460 | ||||||
Loading xslF345X03/ownership.xml…